Steven M. LeVine, Ph.D.
Albert Einstein College of Medicine, 1987
- Neurobiology - multiple sclerosis and globoid cell leukodystrophy
- Vascular - blood-brain barrier disruption and bacteria or toxin induced vessel injury
Our studies utilize a team approach to perform translational research that is directed at identifying pathogenic mechanisms and novel interventions for multiple sclerosis, which is a neurological disease that can cause sensory, motor and/or cognitive declines. Additional collaborative studies address intervention strategies for globoid cell leukodystrophy (Krabbe's disease) and identifying mechanisms of bacteria or toxin induced vessel injury.
Tsau S, Emerson RM, Lynch SG, LeVine SM. Aspirin and multiple sclerosis. BMC Med. 2015; 13: 153. Review
LeVine SM. Albumin and multiple sclerosis. BMC Neurol. 2016; 16: 47. Review
LeVine SM. Is there an increased risk for ischemic stroke in patients with multiple sclerosis, and if so, should preventive treatment be considered? Front. Neurol. 2016; 7: 128. Opinion
Heidker RM, Emerson MR, LeVine SM. Intersections of pathways involving biotin and iron relative to therapeutic mechanisms for progressive multiple sclerosis. Discov. Med. 2016; 22: 381-387. Review
Heidker RM, Emerson MR, LeVine SM (2017) Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis. Neural Regen. Res. 2017; 12: 1262-1267. Review
Krabbe Disease (globoid cell leukodystrophy)
Pedchenko TV, LeVine SM. IL-6 deficiency results in enhanced pathology in twitcher (globoid cell leukodystrophy) mice. Exp. Neurol. 1999; 158: 459-468.
LeVine SM, Pedchenko TV, Bronshteyn IG, Pinson D. L-Cycloserine reduces clinical and pathological signs in mice with globoid cell leukodystrophy (twitcher mice). J. Neurosci. Res. 2000; 60: 231-236.
Biswas S, LeVine SM. Substrate reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy. Pediatric Res. 2002; 51: 40-47.
Sands SA, LeVine SM. (2016) Substrate reduction therapy for Krabbe's disease. J. Neurosci. Res. 2016; 94: 1261-1272. Review
Culley NC, Pinson DM, Chakrabarty A, Mayo MS, LeVine SM. Pathophysiological manifestations in mice exposed to anthrax lethal toxin. Infect. Immun. 2005; 73: 7006-7010.
Terra JK, Cote CK, France B, Jenkins AL, Bozue JA, Welkos SL, LeVine SM, Bradley KA. Cutting edge: Resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J. Immunol. 2010; 184: 17-20.
Terra JK, France B, Cote CK, Jenkins A, Bozue JA, Welkos SL, Bhargava R, Mehrabian M, Pan C, Lusis AJ, Davis RC, LeVine SM, Bradley KA. Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to Bacillus anthracis. PLoS Pathog. 2011; 7(12): e1002469.
Weigel KJ, Rues L, Doyle EJ, Buchheit CL, Wood JG, Gallagher RJ, Kelly LE, Radel JD, Bradley KA, LeVine SM. Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic background. PLoS ONE 2012; 7(7): e40126.
Methods and Designs
Wetzel DL, LeVine SM. Imaging molecular chemistry with infrared microscopy. Science 1999; 285: 1224-1225.
Esch SW, Williams TD, Biswas S, Chakrabarty A, LeVine SM. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: A lipidomics approach. Cell. Mol. Biol. (Noisy-le-grand) 2003; 49: 779-787.
Emerson MR, Gallagher RJ, Marquis JG, LeVine SM. Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design. Comp. Med. 2009; 59: 112-128. Review
Sands SA, Leung-Toung R, Wang Y, Connelly J, LeVine SM. Enhanced histochemical detection of iron in paraffin sections of mouse CNS tissue: Application in the APP/PS1 mouse model of Alzheimer's disease. ASN Neuro. 2016; 8 (5).
Make a Donation
The Jeffrey Dean LeVine memorial fund is used to support biomedical research.
Click here for access to the donation page.